Named on one round in the feed.
Since 2026-04-28
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Coultreon Biopharma Develop autoimmune disease treatments | Series A Verified against 1 of 5 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $125M | 2026-04-28 | [ PART ] |